Compounds and methods for treating multiple sclerosis
US9517237B2 · kind B2 · utility
0Cited by
3References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 7, 2015 |
| Grant date | Dec 13, 2016 |
| Priority date | — |
| Expiry date | May 7, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention described herein pertains to the treatment of multiple sclerosis. In particular, the invention described herein pertains to the treatment of multiple sclerosis using compounds that modulate the action of acrolein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.